RhumbLine Advisers’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
396,726
+37,535
+10% +$884K 0.01% 1092
2026
Q1
$5.37M Buy
359,191
+2,456
+0.7% +$41.9K ﹤0.01% 1368
2025
Q4
$5.19M Sell
356,735
-54,139
-13% -$944K ﹤0.01% 1384
2025
Q3
$7.37M Sell
410,874
-2,744
-0.7% -$40.2K 0.01% 1230
2025
Q2
$7.06M Buy
413,618
+156,476
+61% +$1.57M 0.01% 1227
2025
Q1
$1.86M Buy
257,142
+4,171
+2% +$47.5K ﹤0.01% 1836
2024
Q4
$3.55M Buy
252,971
+6,495
+3% +$96K ﹤0.01% 1595
2024
Q3
$2.92M Buy
246,476
+6,345
+3% +$65.8K ﹤0.01% 1692
2024
Q2
$2.23M Buy
+240,131
New +$1.23M ﹤0.01% 1825

Other funds holding CORZ

RhumbLine Advisers's CORZ Position: Q2 2026 in Review

RhumbLine Advisers increased its Core Scientific (CORZ) stake by 10% in Q2 2026, buying an estimated $884K and bringing the position to 396,726 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #1092.

RhumbLine Advisers first reported a position in CORZ in Q2 2024 and has held it in 9 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • RhumbLine Advisers held 396,726 shares of Core Scientific worth $10.2M as of Q2 2026.
  • RhumbLine Advisers bought 37,535 Core Scientific shares in Q2 2026, an estimated $884K.
  • Core Scientific made up 0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1092 holding.
  • RhumbLine Advisers first reported a position in Core Scientific in Q2 2024 and has held it in 9 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.